Status:
COMPLETED
Ramosetron on Late PONV (Postoperative Nausea and Vomiting)
Lead Sponsor:
Pusan National University Hospital
Conditions:
Postoperative Nausea and Vomiting
Breast Cancer Female
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
The purpose of this study was to evaluate the effectiveness of additional ramosetron injection for controlling late postoperative nausea and vomiting (PONV) after breast surgery in high risk PONV pati...
Detailed Description
The investigators included high risk patients of PONV with a score of 3 or more as measured by the Apfel's score and over 18 years old who receive breast surgery and intravenous patient controlled ana...
Eligibility Criteria
Inclusion
- age over 18 years
- American Society of Anesthesiologists (ASA) physical status I or II
- requesting IV PCA (patient control of analgesia) for pain control
- the high-risk group of PONV with a score of 3 or more as measured by the Apfel's score.
Exclusion
- emergency operation
- re-operation
- drug abuse, allergy
- major organ disease (gastrointestinal, cardiovascular, respiratory, cerebral, renal or hepatic disease)
- smoker
- pregnancy
- lactation
- previously use of antiemetics or systemic steroids within 48 before surgery
Key Trial Info
Start Date :
December 17 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 31 2021
Estimated Enrollment :
144 Patients enrolled
Trial Details
Trial ID
NCT05326360
Start Date
December 17 2020
End Date
October 31 2021
Last Update
April 19 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Pusan National University Hopsital
Busan, South Korea, 49241